Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

Clinical trial NCT06546007 · RECRUITING

Trial details

NCT number: NCT06546007
Sponsor: Rarecells Diagnostics SAS
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer Pulmonary Neoplasm

Start date: 2024-11-13
Primary completion: 2025-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.